Wednesday, 22 July 2026

 

 

LATEST NEWS "Democracy functions through representation; elected representatives should raise people's issues in Parliament": Anil Vij Make Environmental Protection a People's Movement: CM Nayab Singh Saini Use Treated Water Scientifically and in a Planned Manner : Nayab Singh Saini Nation's Youth & Farmers Are on Roads, but Instead of Dialogue, BJP Govt Is Using Force to Silence Their Voices : Baltej Pannu PM Modi Recognised Me Instantly; His Affection for Party Workers is Unparalleled : Vineet Joshi NEET (UG)-2026 All India Rank-2 Panshul Bansal Calls on Chief Minister CM Condoles Demise of Former MLA Rajpal Bhukhri, Visits Bereaved Families in Narayangarh Every eligible individual must get their name registered in the voter list to strengthen democracy: Nayab Singh Saini Chief Electoral Officer Reviews Progress of Special Intensive Revision of Electoral Rolls Air India Selects New JFK Terminal 6 For Future Operations IIHMR University Convocation 2026 Celebrates India's Next Generation of Healthcare Leaders 46 KCP-PWG Militants Surrender in Major Manipur Breakthrough NABARD's ₹15,056-Crore Push Reshapes Rural Haryana CM Suvendu Adhikari launches app to report electricity theft Vipul Goel chairs 8th Board Meeting of Haryana Airports Development Corporation Government Focused on Equipping ITI Students with Modern Skills for Industry- Gaurav Gautam Dr Himanshu Aggarwal Conducts Surprise Inspection of Seva Kendra and Sub-Registrar Office Amarinder Singh Raja Warring condemns Mann for dancing to Shah’s tunes Ahead of Monsoon, Baliawal Seeks Urgent Repair of Sahnewal Embankments and Action Against Illegal Mining Dr. Jitendra Singh meets Rahul Gandhi as Cong leadership protests outside PM’s house J&K to Host Mega Job Fair with 10,000+ Vacancies

 

'Mild' link between Pfizer, Moderna jabs & heart inflammation: WHO

Delta Plus Covid variant, Delta Covid-19 variant, Health, Study, Coronavirus, Research, Researchers, COVID 19, Novel Coronavirus, Fight Against Corona, Covaxin, Covishield, Oxygen, Oxygen Cylinders, SARS-CoV-2, Sputnik V, Oxygen Plants, Pfizer, Astra Zeneca, Remdesivir, Geneva, World Health Organisation, WHO

Web Admin

Web Admin

5 Dariya News

Geneva , 11 Jul 2021

Last updated on: Jul 11, 2021, 00:00 IST

The World Health Organisation (WHO) has found very rare cases of heart inflammation following vaccination with the mRNA Covid-19 vaccines such as Pfizer and Moderna, but the benefits still outweigh the risks.The cases were mild, and found more often in young men after the second dose, said the global health body.WHO's Global Advisory Committee on Vaccine Safety (GACVS) said that cases of myocarditis and pericarditis had been reported in the US and several other countries. Myocarditis is an inflammation of the heart muscle, while pericarditis is an inflammation of the lining that surrounds the heart."Very rare cases of myocarditis and pericarditis have been observed following vaccination with the mRNA Covid-19 vaccines. These cases occurred more often in younger men and after the second dose of the vaccine, typically within a few days after vaccination. Current evidence suggests a likely causal association between myocarditis and the mRNA vaccines," the WHO said in a statement.The available data also suggest that the immediate cause of myocarditis and pericarditis following vaccination is generally mild and responds to rest, treatment with nonsteroidal anti-inflammatory drugs, etc.Nearly 40.6 cases of myocarditis per million second doses among males and 4.2 cases per million among females have been reported as of June 11, 2021 in people aged between 12 and 29 years who received the mRNA Covid-19 vaccines, according to the data in the US Vaccine Adverse Events Reporting System (VAERS).For persons over 30 years of age, the reporting rates were 2.4 and 1.0 per million second doses, respectively, for males and females.The link was also confirmed by the European Medicines Agency, Europe's drug regulator.EMA's Pharmacovigilance Risk Assessment Committee (PRAC) confirmed "a plausible causal relationship between myocarditis and the mRNA vaccines" in Europe.Yet, "the benefits of mRNA Covid-19 vaccines continue to outweigh the risks of myocarditis and pericarditis even among young people, the WHO said.Symptoms indicative of myocarditis or pericarditis include new onset and persisting chest pain, shortness of breath, or palpitations following vaccination.The global health body advised clinicians to be aware of the risk of myocarditis and pericarditis with mRNA vaccines and people most likely to be affected -- adolescent or young males. It also asked vaccinated individuals to seek immediate medical attention if they develop any such conditions.

 

Tags: Delta Plus Covid variant , Delta Covid-19 variant , Health , Study , Coronavirus , Research , Researchers , COVID 19 , Novel Coronavirus , Fight Against Corona , Covaxin , Covishield , Oxygen , Oxygen Cylinders , SARS-CoV-2 , Sputnik V , Oxygen Plants , Pfizer , Astra Zeneca , Remdesivir , Geneva , World Health Organisation , WHO

 

 

related news

 

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2026 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD